1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Alcon Inc.
  6. Summary
    ALC   CH0432492467

ALCON INC.

(ALC)
  Report
Delayed Swiss Exchange  -  11:30 2022-07-01 am EDT
67.42 CHF   +1.11%
06/16Argus Adjusts Alcon Price Target to $78 From $88, Maintains Buy Rating
MT
06/06Football Star Cooper Kupp Encourages Eye Allergy Sufferers to Find the Right Tool for the Job with Pataday
BU
05/25GLOBAL MARKETS LIVE : Glencore, Starbucks, Apple, Lyft, Intuit...
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
06/27/2022 06/28/2022 06/29/2022 06/30/2022 07/01/2022 Date
66.62(c) 66.44(c) 66.04(c) 66.68(c) 67.42(c) Last
633 123 591 584 455 821 958 934 580 426 Volume
+0.73% -0.27% -0.60% +0.97% +1.11% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 8 835 M - -
Net income 2022 571 M - -
Net Debt 2022 2 270 M - -
P/E ratio 2022 59,8x
Yield 2022 0,27%
Sales 2023 9 346 M - -
Net income 2023 797 M - -
Net Debt 2023 1 452 M - -
P/E ratio 2023 43,5x
Yield 2023 0,35%
Capitalization 34 407 M 34 407 M -
EV / Sales 2022 4,15x
EV / Sales 2023 3,84x
Nbr of Employees 24 000
Free-Float 98,0%
More Financials
Company
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (54.9%): consumables (52.6% of net sales), implantable products (30.4%) and other products (17%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive... 
More about the company
Ratings of Alcon Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about ALCON INC.
06/16Argus Adjusts Alcon Price Target to $78 From $88, Maintains Buy Rating
MT
06/06Football Star Cooper Kupp Encourages Eye Allergy Sufferers to Find the Right Tool for t..
BU
05/25GLOBAL MARKETS LIVE : Glencore, Starbucks, Apple, Lyft, Intuit...
05/24Swiss Eye Care Company Alcon Prices $536 Million Note Offering
MT
05/24Alcon Prices Public Offering of 500 Million Euros of Senior Notes
MT
05/24Alcon Prices EUR 500.0 Million Senior Notes Offering
BU
05/24Game Developer -BLADE RUNNER RPG on Kickstarter - Three Days Left
AQ
05/23GLOBAL MARKETS LIVE : Tesla, Kohl's, Apple, JPMorgan, Bank of America...
05/23Kala Announces Entry into Definitive Agreement to Sell EYSUVIS and INVELTYS to Alcon In..
AQ
05/23Kala Pharmaceuticals to Sell EYSUVIS, INVELTYS to Alcon
MT
05/23Switzerland's Alcon To Purchase Eysuvis Eye Drops From Kala Pharmaceuticals For $60 Mil..
MT
05/23Alcon to Acquire EYSUVIS Adding to Its Ophthalmic Eye Drop Portfolio
BU
05/20Moody's Reiterates Alcon Ratings As Aging Population Drives Eye Care Demand
MT
05/12Alcon's Continued Recovery From COVID Drove Q1 Beat Despite 'Increased' Currency, Infla..
MT
05/12Morgan Stanley Adjusts Price Target for Alcon to $83 From $92, Maintains Equalweight Ra..
MT
More news
News in other languages on ALCON INC.
06/03Aktien Schweiz gehen etwas leichter ins Wochenende
06/02Aktien Schweiz gehen etwas fester aus dem Handel
05/25Aktien Schweiz gut behauptet - Richemont auf Erholungskurs
05/25BOLSA DE MADRID : Se queman ídolos
05/25On brûle les idoles
More news
Analyst Recommendations on ALCON INC.
More recommendations
Stock Trading Strategies
ALCON INC. - 03/02
The trend should regain control
BUY
More Stock Trading Analysis
Chart ALCON INC.
Duration : Period :
Alcon Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ALCON INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 70,03 $
Average target price 83,44 $
Spread / Average Target 19,1%
EPS Revisions
Managers and Directors
David J. Endicott Chief Executive Officer & Director
Timothy C. Stonesifer Chief Financial Officer & Senior Vice President
F. Michael Ball Chairman
Franck Leveiller Vice President & Head-R&D Vision Care
Sue-Jean Lin SVP, Chief Information & Transformation Officer
Sector and Competitors
1st jan.Capi. (M$)
ALCON INC.-16.50%34 407
THE COOPER COMPANIES, INC.-23.97%15 714
AUTEK CHINA INC.-2.44%7 474
MENICON CO., LTD.-8.82%1 738
WARBY PARKER INC.-75.60%1 306
PEGAVISION CORPORATION-1.64%986